Transformation in mycosis fungoides: The role of methotrexate

Journal of Cutaneous Medicine and Surgery

Volumn 6, Issue 2, 2002, Pages 109-116

  Abd El Baki, Jasmin ^a   Demierre, Marie France ^a   Li, Ning ^a   Foss, Francine M ^a  

^a DOB 801A ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ARTICLE; CELL TRANSFORMATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; HUMAN; INCIDENCE; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; MALIGNANT TRANSFORMATION; MYCOSIS FUNGOIDES; PRIORITY JOURNAL; RISK FACTOR;

ADULT; AGED; AGED, 80 AND OVER; CELL TRANSFORMATION, NEOPLASTIC; DERMATOLOGIC AGENTS; FEMALE; GENES, T-CELL RECEPTOR GAMMA; HUMANS; IMMUNOPHENOTYPING; IMMUNOSUPPRESSIVE AGENTS; LYMPHOMA, LARGE-CELL; MALE; METHOTREXATE; MIDDLE AGED; MYCOSIS FUNGOIDES; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; SKIN NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0036266099     PISSN: 12034754     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10227-001-0040-y     Document Type: Article

References (37)

1. Cutaneous T-cell lymphoma
2. Cytologic transformation in cutaneous T-cell lymphoma: A clinicpathologic entity associated with poor prognosis
3. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma
4. Prognostic significance of cytomorphology in the cutaneous T-cell lymphomas
5. Transformation of mycosis fungoides: T-cell receptor β gene analysis demonstrates a common clonal origin for plaque-type mycosis fungoides and CD30+ large-cell lymphoma
6. Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: Results in twenty-nine patients
7. Methotrexate-associated lymphoma in patients with rheumatoid arthritis: Report of two case
8. Association of methotrexate, rheumatoid arthritis and lymphoma: Report of 2 cases and literature review
9. Review of United States data on neoplasms in rheumatoid arthritis
10. Non-Hodgkin's lymphoma in rheumatoid arthritis
11. Incidence of cancer among men with the Felty syndrome
12. Neoplasms of the immune system in rheumatoid arthritis
13. Increased risk of lymphoma in sicca syndrome
14. Reversible lymphomas associated with Epstein-Barr virus occurring during methotrexate therapy for rheumatoid arthritis and dermatomyositis
15. Methotrexate related B lymphoproliferative disease in a patient with rheumatoid arthritis: Role of Epstein-Barr virus infection
16. Mycosis fungoides: The pathology of extracutaneous involvement
17. Report of the Committee on Staging and Classification of Cutaneous T-Cell Lymphomas
18. Transformation of cutaneous T-cell lymphoma to large-cell lymphoma: A clinicopathologic and immunologic study
19. The immunophenotyping of bone marrow biopsies and aspirates: Frozen section techniques
20. High incidence of EBV genome in CD-30 positive non-Hodgkin's lymphoma
21. Detection of clonal T-cell receptor γgene rearrangements in early mycosis fungoides/Sezary syndrome by polymerase chain reaction and denaturing gradient gel electrophoresis (PCR/DGGE)
22. Polymerase chain reaction-denaturing gradient gel electrophoresis (PCR/DGGE) based detection of clonal T-cell receptor γ gene rearrangements on paraffin-embedded cutaneous biopsies in cutaneous T-cell lymphoproliferative disorders
23. Lymphomatoid papulosis and associated cutaneous lymphoproliferative disorders exhibit a common clonal origin
24. Non-parametric estimation from incomplete observations
25. Spectrum of primary cutaneous CD30 (Ki-1)-positive lyrnphoproliferative disorders: A proposal for classification and guidelines for management and treatment
26. Transformation of mycosis fungoides/Sezary syndrome: Clinical characteristics and prognosis
27. Prognosis in cutaneous T-cell lymphoma by skin stage: Long-term survival in 489 patients
28. Clinical stage 1A (limited patch and plaque) mycosis fungoides: A long-term outcome analysis
29. Clinical characteristics and long-term outcome of patients with generalized patch and/or plaque (T2) mycosis fungoides
30. Molecular evidence for a clonal relationship between lymphomatoid papulosis and ki-1 positive large cell anaplastic lymphoma
31. Lymphomatoid papulosis followed by Ki-1 positive anaplastic large cell lymphoma: Proliferation of a common T-cell clone
32. Reversible cutaneous lymphoma occurring during methotrexate therapy
33. Anti-inflammatory and immunoregulatory action of methotrexate in the treatment of rheumatoid arthritis: Evidence of increased interleukin-4 and interleukin-10 gene expression demonstrated in vitro by competitive reverse polymerase chain reaction
34. Th2 cytokine mRNA expression in skin in cutaneous T-cell lymphoma
35. Methotrexate used for psoriasis and the risk of noncutaneous or cutaneous malignancy
36. Is methotrexate therapy for psoriasis carcinogenic?
37. No increase in second tumors after cytotoxic chemotherapy for gestational trophoblastic tumors